References
- Herwaldt BL. Leishmaniasis. Lancet. 1999;354(9185):1191–1199.
- Fatima F, Khalid A, Nazar N, Abdalla M, Mohomed H, Toum AM, In vitro assessment of anti-cutaneous leishmaniasis activity of some Sudanese plants. Türkiye Parazitol Derg. 2005;29:3–6.
- Abass K, Saad H, Abd-Elsayed AA. The first case of isolated facial cutaneous leishmaniasis in a Down syndrome infant: A case report and review of the literature. Cases J. 2009;2(1):13.
- Von Stebut E. Cutaneous leishmania infection: Progress in pathogenesis research and experimental therapy. Exp Dermatol. 2007;16(4):340–346.
- Jaafari MR, Behravan J, Bodagh Abadi A, Ramezani M. Evaluation of leishmanicidal effect of Euphorbia myrsinites extract by in vitro antileishmanial assay using promastigote of Leishmania major. Iranian J Basic Med Sci. 2005;8:295–298.
- Bryceson A. Therapy in man. In: Peters W, Killick-Kendrick R, editors. The leishmaniases. London: Elsevier; 1987. p. 847–869.
- Garnier T, Croft SL. Topical treatment for cutaneous leishmaniasis. Curr Opin Investig Drugs. 2002;3:538–544.
- Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A. 2000;97:8841–8848.
- Mauël J, Ransijn A, Buchmüller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivates. J Leukoc Biol. 1991;49:73–82.
- Gradoni L, Ascenzi P. Nitric oxide and anti-protozoan chemotherapy. Parassitologia. 2004;46(1-2):101–103.
- Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, Vincendeau P, Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immun. 2002;70(7):3727–3735.
- Kröncke KD, Suschek CV. Adulterated effects of nitric oxide-generating donors. J Invest Dermatol. 2008;128:258–260.
- Jowkar F, Jamshidzadeh A, Pakniyat S, Namazi MR. Efficacy of nitric oxide-liberating cream on pityriasis versicolor. J Dermatolog Treat. 2009;1:1–4.
- Oliveira SH, Fonseca SG, Romão PR, Ferreira SH, Cunha FQ. Nitric oxide mediates the microbicidal activity of eosinophils. Mem Inst Oswaldo Cruz. 1997;92(suppl 2):233–235.
- Nahrevanian H, Najafzadeh M, Hajihosseini R, Nazem H, Farahmand M, Zamani Z. Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway. Korean J Parasitol. 2009;47(2):109–115.
- Nahrevanian H, Farahmand M, Aghighi Z, Assmar M, Amirkhani A. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: An Iranian strain of cutaneous leishmaniasis. Exp Parasitol. 2007;116(3):233–240.
- Davidson RN, Yardley V, Croft SL, Konecny P, Benjamin N. A topical nitric oxide-generating therapy for cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2000;94(3):319–322.
- López-Jaramillo P, Ruano C, Rivera J, Terán E, Salazar-Irigoyen R, Esplugues JV, Treatment of cutaneous leishmaniasis with nitric-oxide donor. Lancet. 1998;351(9110):1176–1177.
- Mosleh IM, Geith E, Natsheh L, Schönian G, Abotteen N, Kharabsheh S. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol. 2008;58(4):617–624.
- Bassiouny A, El Meshad M, Talaat M, Kutty K, Metawaa B. Cryosurgery in cutaneous leishmaniasis. Br J Dermatol. 1982;107(4):467–474.